CCompany Historically Provides H-1B Sponsorship
CVS Health runs pharmacies, health insurance plans and medical clinics for individuals, employers and government programs across the United States. Its businesses include CVS Pharmacy, the Aetna insurer and Caremark, which manages prescription coverage and negotiates drug prices for health plans. Patients fill prescriptions in stores or by mail and receive care through walk-in clinics, primary care centers and home visits. The company earns money from prescription sales, insurance premiums, plan administration fees and clinical services, combining coverage with places to obtain treatment. Its first store opened in 1963, and its headquarters are in Woonsocket, Rhode Island.
Work here?Claim your company
Industries
Company Size
10,001+
Company Stage
IPO
Headquarters
Woonsocket, Rhode Island
Founded
1963
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$7B
Above
Industry Average
Funded Over
2 Rounds
CVS Health beat Wall Street expectations in the third quarter of 2026, but its shares fell. The stock trades at $81.22, down from $91.60 before the earnings. Revenue rose 5.4% year on year to $108.4 billion, against analyst estimates of $104.2 billion. Adjusted earnings per share (EPS) were $2.09 versus the $1.65 expected, and adjusted operating income hit $4.19 billion. Management raised its full-year adjusted EPS guidance to $8.20 at the midpoint. Analysts focused on the planned separation of the company. Chief executive officer David Joyner said the decision came from a position of strength. Chief financial officer Brian Newman said both new companies would keep investment-grade credit ratings, and that some one-time and stranded costs are manageable.
Mark Cuban has dismissed CVS Health's plan to split into two independent, publicly traded companies as a shareholder play. In a November 4 post on X, he said the move "changes nothing for patients or anyone who pays for insurance or care." CVS chief executive officer David Joyner told CNBC the split would "improve affordability and improve coverage." Cuban said Joyner was posturing in response to the Break Up Big Medicine Act, and urged Congress to pass it. CVS is the second-largest US health insurer by revenue, according to S&P Global. It reported third-quarter revenues of $108.4 billion, up 5.4%, and projected 2026 revenues of $420 billion. Some healthcare experts agreed that a paper split does not help patients unless ownership and incentives change.
CVS Health shares fell 12.5% on November 4, the day it reported fiscal Q3 2026 results and announced plans to split into two publicly traded companies. The S&P 500 rose 1.6% that day. By November 6, CVS was down 8.3% from its pre-report close. The quarter beat forecasts. Adjusted earnings were $2.09 a share against the $1.67 expected, and revenue was $108 billion against $106 billion. CVS raised its 2026 adjusted earnings outlook to at least $8.20 a share, from $7.90 to $8.10. CVS Health will keep Aetna, Caremark and Oak Street, while CVS Pharmacy will hold the retail stores, mail order and MinuteClinic. The split is expected to be tax free and complete in the first half of 2028. CVS now expects at least $8.65 of adjusted earnings a share for 2027, up from $8.45. It will give formal 2027 guidance in February 2027.
CVS Health reported third-quarter net income of $2.17 billion, or $1.68 per share, beating Wall Street expectations. Adjusted for one-time gains and costs, earnings were $2.09 per share. Analysts surveyed by Zacks Investment Research had expected $1.62. The Woonsocket, Rhode Island-based drugstore chain and pharmacy benefits manager posted revenue of $108.4 billion, above the $105.04 billion analysts forecast. CVS expects full-year earnings of $8.20 per share.
CVS Health is considering a breakup that could separate its retail pharmacy chain from its insurance business, the Financial Times reported, citing people familiar with the matter. The talks are at an early stage and no final decision has been made. CVS could spin off the pharmacy arm as a separately listed company. Aetna and pharmacy benefit manager Caremark would stay together under one corporate entity. A split would reverse CVS's strategy of building an integrated healthcare business through acquisitions, including its roughly $78 billion purchase of Aetna in 2018. The move comes as pharmacy benefit managers face growing political and regulatory scrutiny in the US. CVS reported record revenue of $402.1 billion in 2025, up 7.8%. Its shares rose 1.2% in extended trading ahead of third-quarter results on Wednesday.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
10,001+
Company Stage
IPO
Headquarters
Woonsocket, Rhode Island
Founded
1963
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs